Accelerate Diagnostics, Inc. (LON:0H8E)
0.0126
+0.0001 (0.80%)
At close: May 22, 2025
Accelerate Diagnostics Revenue
In the year 2024, Accelerate Diagnostics had annual revenue of $11.70M USD, down -2.99%. Accelerate Diagnostics had revenue of $2.82M in the quarter ending December 31, 2024, a decrease of -6.97%.
Revenue
$11.70M
Revenue Growth
-2.99%
P/S Ratio
0.01
Revenue / Employee
$109.33K
Employees
107
Market Cap
103.99K GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.70M | -361.00K | -2.99% |
Dec 31, 2023 | 12.06M | -693.00K | -5.43% |
Dec 31, 2022 | 12.75M | 970.00K | 8.23% |
Dec 31, 2021 | 11.78M | 617.00K | 5.53% |
Dec 31, 2020 | 11.17M | 1.87M | 20.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Accelerate Diagnostics News
- 2 months ago - Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - PRNewsWire
- 3 months ago - Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance - PRNewsWire
- 3 months ago - Accelerate Diagnostics reports Q4 results - Seeking Alpha
- 3 months ago - Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PRNewsWire
- 6 months ago - Accelerate Diagnostics reports preliminary FY 2024 revenue of $11.7 million - Seeking Alpha
- 6 months ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PRNewsWire
- 6 months ago - GRIFFIN ASSET MANAGEMENT, INC. Reduces Holdings in Accelerate Diagnostics Inc - GuruFocus
- 8 months ago - Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript - Seeking Alpha